Eva A. Ebbing

Stromal-derived interleukin 6 drives epithelial-to-mesenchymal transition and therapy resistance in esophageal adenocarcinoma

Eva A. Ebbing, Amber P. van der Zalm, Anne Steins et al. · Proceedings of the National Academy of Sciences · 2019 · 194 citations · Full text

Esophageal Cancer, Immunology, Pathology +16

Establishment of patient-derived xenograft models and cell lines for malignancies of the upper gastrointestinal tract

Helene Damhofer, Eva A. Ebbing, Anne Steins et al. · Journal of Translational Medicine · 2015 · 74 citations · Full text

Esophageal Adenocarcinoma Cells and Xenograft Tumors Exposed to Erb-b2 Receptor Tyrosine Kinase 2 and 3 Inhibitors Activate Transforming Growth Factor Beta Signaling, Which Induces Epithelial to Mesenchymal Transition

Eva A. Ebbing, Anne Steins, Evelyn Fessler et al. · Gastroenterology · 2017 · 41 citations

Cancer Research, Esophageal Cancer, Medicine +12

ADAM10-mediated release of heregulin confers resistance to trastuzumab by activating HER3

Eva A. Ebbing, Jan Paul Medema, Helene Damhofer et al. · Oncotarget · 2016 · 33 citations · Full text

Chemoradiation induces epithelial‐to‐mesenchymal transition in esophageal adenocarcinoma

Anne Steins, Eva A. Ebbing, Aafke Creemers et al. · International Journal of Cancer · 2019 · 26 citations · Full text